48mon MSN
Israeli man facing early-onset Alzheimer's develops potential treatment for Parkinson's disease
Initially turned away, Ofer Shina built X-tosis around Prof. Varda Shoshan-Barmatz's research. The startup has a $2.74 ...
PRImus-AD met its primary safety endpoint, with PRI-002 demonstrating a favorable safety and tolerability profile The study did not meet its ...
AriBio’s erectile dysfunction med-turned Alzheimer’s disease candidate mirodenafil has delivered some mixed results from a ...
The study author told Newsweek an individual's risk depends on many factors, including age, genetics and overall health.
A closely watched study found no cognitive benefit from a brain-stimulating headset designed to treat Alzheimer's disease.
At the 2026 Clinical Trials on Alzheimer’s Disease conference, AriBio reported that AR1001 slowed cognitive decline more than ...
A positive amyloid test can now mean an Alzheimer's diagnosis, even with no symptoms. A physician explains the debate, the ...
Cognito’s Spectris®, Showed Consistent Slowing of Cognitive and Functional Decline in Early Symptomatic AD in HOPE Pivotal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results